Publication:
Both activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model

dc.contributor.authorElibol, Birsen
dc.contributor.institutionauthorELİBOL, BİRSEN
dc.date.accessioned2019-12-20T20:59:12Z
dc.date.available2019-12-20T20:59:12Z
dc.date.issued2019-12-01
dc.identifier.citationElibol B., -Both activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model-, Advances in Clinical Toxicology, cilt.4, no.175, ss.1-8, 2019
dc.identifier.doi10.23880/act-16000175
dc.identifier.urihttps://hdl.handle.net/20.500.12645/10643
dc.language.isoen
dc.titleBoth activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model
dc.typeArticle
dspace.entity.typePublication
local.avesis.id73cea2b1-f297-4af5-b824-8a522a4d5eda
local.publication.isinternational1
relation.isAuthorOfPublication1b1887fb-6b32-44b1-9d9f-416616dc6734
relation.isAuthorOfPublication.latestForDiscovery1b1887fb-6b32-44b1-9d9f-416616dc6734
Files